Skip to content
Vertex Pharmaceuticals logo

Current Assets

Vertex Pharmaceuticals·Balance Sheet Statement·16 metrics

Breakdown

MetricQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Work in process$657.6M$750.1M$768.8M$901.2M$1.1B$1.1B$1.2B$1.2B
Raw materials$112.1M$141.1M$252M$250.5M$221.4M$278.6M$259.8M$267.4M
Inventories$914.6M$1.1B$1.2B$1.4B$1.5B$1.6B$1.7B$1.8B

Metrics

Accounts receivable, net

View metric

AFS and Trading Securities - Unrealized Loss Position (>=12 Months)

View metric

AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value

View metric

AFS and Trading Securities - Unrealized Loss Position Fair Value

View metric

Cash and cash equivalents

View metric

Finished goods

View metric

Short- term Investments

View metric

Current Equity Amortized Cost

View metric

Equity Securities (FV-NI) - Cost Basis

View metric

Raw materials

View metric

Work in process

View metric

Inventories

View metric

Prepaid expenses and other current assets

View metric

Restricted cash

View metric

Short-term investments

View metric

Total current assets

View metric